The Patent Finder

Methods for Treating Hypercholesterolemia

Ionis Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 60/867,395, filed Nov 27, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,084,437Methods for Treating Hypercholesterolemia
In force
 · High confidence
UsedRemaining
Ionis Pharmaceuticals, Inc.In forceHigh confidence
US 8,664,190Methods for Treating Hypercholesterolemia
In force
 · Medium confidence
Ionis Pharmaceuticals, Inc.In forceMedium confidence
US 8,912,160Methods for Treating Hypercholesterolemia
In force
 · Medium confidence
Ionis Pharmaceuticals, Inc.In forceMedium confidence
US 9,650,636Methods for Treating Hypercholesterolemia
In force
 · Medium confidence
Ionis Pharmaceuticals, Inc.In forceMedium confidence
US 10,858,657Methods for Treating Hypercholesterolemia
In force
 · Low confidence
Ionis Pharmaceuticals, Inc.In forceLow confidence
US 11,530,410Methods for Treating Hypercholesterolemia
In force
 · Low confidence
Ionis Pharmaceuticals, Inc.In forceLow confidence
Application 15/483,992Methods for Treating Hypercholesterolemia
Abandoned
Abandoned Aug 13, 2018
Ionis Pharmaceuticals, Inc.AbandonedAbandoned Aug 13, 2018
Application 17/987,064Methods for Treating Hypercholesterolemia
Abandoned
Abandoned Dec 16, 2024
Ionis Pharmaceuticals, Inc.AbandonedAbandoned Dec 16, 2024
Application 18/959,229Methods for Treating Hypercholesterolemia
Pending
Not granted
Ionis Pharmaceuticals, Inc.PendingNot granted
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Ionis Pharmaceuticals, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited